Post-Hoc Live: MAHA, the new Trump CDC pick and RFK's vaccine agenda

April 23, 2026 01:56 PM EDTUpdated April 24, 11:34 AM FDA+Coronavirus Is the CD­C's an­ti-vax era com­ing to an end? Un­pack­ing MA­HA with Why Should I Trust You? Drew Armstrong Executive Editor MA­HA’s sway over HHS could face a fresh test now that Pres­i­dent Trump has a new pick for CDC di­rec­tor: Er­i­ca Schwartz, a for­mer deputy sur­geon gen­er­al.

The po­si­tion has been emp­ty since Au­gust, when Su­san Monarez was oust­ed af­ter clash­es with HHS Sec­re­tary Robert F. Kennedy Jr. Like Monarez, Schwartz is a more tra­di­tion­al pub­lic health choice, with a track record of sup­port­ing vac­ci­na­tion.

But a cru­cial ques­tion will be just how much in­de­pen­dence she has from Kennedy’s in­flu­ence and agen­da on im­mu­niza­tion. To­day on Post-Hoc Live at 11 a.m. ET, we’ve got a crossover episode!

We’ll be joined by Why Should I Trust You? host Brin­da Ad­hikari, whose show takes a look at the MA­HA move­ment and chang­ing trust in pub­lic health. Ad­hikari will be chat­ting with me and End­points’ MA­HA ex­pert Max Bay­er to talk about how Schwartz could sta­bi­lize a tur­bu­lent CDC and what the pick says about MA­HA’s stand­ing in Trump­world.

We’ll be stream­ing live on YouTube, and you can set a cal­en­dar alert to get a re­minder. See you there! — Drew Arm­strong, Ex­ec­u­tive Ed­i­tor AUTHOR Drew Armstrong Executive Editor drew@endpointsnews.com @ArmstrongDrew Drew Armstrong on LinkedIn